# Transcranial Direct Current Stimulation (tDCS) Augmentation by D-Cycloserine as a Treatment for Depression

> **NCT00869765** · PHASE2 · COMPLETED · sponsor: **The University of New South Wales** · enrollment: 5 (actual)

## Conditions studied

- Major Depressive Disorder
- Bipolar Disorder

## Interventions

- **DRUG:** D-Cycloserine
- **DEVICE:** tDCS (Eldith DC-Stimulator (CE certified))

## Key facts

- **NCT ID:** NCT00869765
- **Lead sponsor:** The University of New South Wales
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2010-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00869765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00869765, "Transcranial Direct Current Stimulation (tDCS) Augmentation by D-Cycloserine as a Treatment for Depression". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00869765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*